Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/21/2003US20030157623 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157621 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157620 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157619 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157617 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157616 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157614 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157613 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157612 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157611 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157610 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157609 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157608 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157607 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157606 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157605 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157604 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157603 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157602 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/21/2003US20030157601 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/21/2003US20030157599 Comprises nucleotide sequence coding prostaglandin E receptor (EP3) for diagnosis and treatment of atherosclerotic diseases; restriction fragment length polymorphisms
08/21/2003US20030157598 Membrane protein associated with nuclear factor activated t-cells for diagnosing and treating cell proliferative/kidney disorders
08/21/2003US20030157595 Fungal culture for generating neutral or alkaline glucanases for biopolishing, defribillating, bleaching, dyeing, or desizing textiles; laundry detergents
08/21/2003US20030157594 Cell-free extract and glycoprotein synthesis system
08/21/2003US20030157593 Novel fructosyl peptide oxidase
08/21/2003US20030157592 Nucleotide sequences coding tocopherol and carotenoid metabolism related proteins (TCMRP) for use in food processing, animal feeds and cosmetic
08/21/2003US20030157578 Providing a yeast cell containing an aequorin-encoding deoxyribonucleic acid sequence expressibly linked to a consituttive yeast promoter, incubating the yeast cell, measuring the amount of aequorin produced
08/21/2003US20030157577 Using myeloid cells which are expressing IAP (Integrin Associated Protein) and screening the substances (antibodies) having property of causing apoptosis
08/21/2003US20030157573 Use of Axl receptor for diagnosis and treatment of renal disease
08/21/2003US20030157562 Protein is characterized in that it elicits an immunological response from a mammal; has been prepared by expression in a bacterium other than Borrelia burgdorferi; free of other Borrelia proteins and has specific amino acid sequence
08/21/2003US20030157554 Purified complex of a first and second polypeptide, where at least one of the polypeptides is an insulin-signaling, vesicular-trafficking, calcium binding protein; complexing segments of first and second polypeptides; decomplexing
08/21/2003US20030157552 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
08/21/2003US20030157551 Attenuated Coryneform bacteria, which express attenuated amounts MtrA and/or MtrB proteins or gene products that have response regulator or histidine protein kinase activity
08/21/2003US20030157548 Method for diagnosing schizophrenia using objective indices
08/21/2003US20030157547 Combining mixture of RNA polymerase and reversible inhibitor of RNA polymerase (reversible inhibitor does not hybridize to a target nucleic acid sequence), with sample suspected to contain target nucleic acid, exposing to amplification
08/21/2003US20030157542 Molecular torches
08/21/2003US20030157536 Controlling transcription factor; genetic engineering expression vector
08/21/2003US20030157534 DNA immunization with libraries of minigenes encoding degenerate variants of major histocompatability class l restricted epitopes
08/21/2003US20030157533 Nucleic acid labeling by Thermoanaerobacter thermohydrosulfuricus DNA polymerase I variants
08/21/2003US20030157531 TAOJIKs as modifiers of the beta-catenin pathway and methods of use
08/21/2003US20030157530 cDNA for human methylenetetrahydrofolate reductase
08/21/2003US20030157529 Methods for determining transcriptional activity
08/21/2003US20030157523 Cell and tissue arrays and microarrays and methods of use
08/21/2003US20030157520 Heat resistanct protein; purification by filtration
08/21/2003US20030157516 Medical diagnosis; binding with adenine
08/21/2003US20030157515 DNA-level rice palatability evaluation method, and method of selecting palatable rice through analysis of half grain of unhulled/unpolished rice
08/21/2003US20030157514 Therapy for immunology disorders; kinase inhibitors; anticancer agents
08/21/2003US20030157513 Controlling fat accumulation; detecting water soluble triglycerides
08/21/2003US20030157511 Polynucleotides; receptor for melamin concentrating hormone
08/21/2003US20030157510 Method for detecting cytosine methylation in dna samples
08/21/2003US20030157509 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns, are portable and reusable
08/21/2003US20030157508 Genetic engineering; gene therapy
08/21/2003US20030157506 Interferon-alpha induced genes
08/21/2003US20030157502 Induce apoptosis; antitumor, anticancer agents
08/21/2003US20030157501 Measuring gene expression; calibration sensitivity to cancer, thyroid disease
08/21/2003US20030157495 Hybrid Dna sequence; amplification, polymerase chain reactions
08/21/2003US20030157494 Smooth muscle cell promoter and uses thereof
08/21/2003US20030157492 Method to isolate DNA
08/21/2003US20030157487 Nucleic acid ligands
08/21/2003US20030157485 Forensic analysis; chromosome marking
08/21/2003US20030157483 Compositions and methods utilizing DNA polymerases
08/21/2003US20030157482 Binding labeled antibody to protein; measurement; calibration
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157477 Detection, recovering of genes
08/21/2003US20030157476 Immortalized human keratinocyte cell line
08/21/2003US20030157230 Process for stabilizing proteins in an acidic environment with a high-ester pectin
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157131 Interferon inducing genetically engineered attenuated viruses
08/21/2003US20030157130 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging
08/21/2003US20030157128 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157121 Virulence genes, proteins, and their use
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157109 Antibodies directed to PDGFD and uses thereof
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157103 Human amine transporter antibodies
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157096 Used to antagonize the effects of T-cell inducible factor in certain diseases
08/21/2003US20030157095 Invasive and metastic ability of breast cancer cells is proportional to level of peripheral type benzodiazepine receptor expressed, correlates with subcellular localization in that it is found in the nucleus of aggressive tumor cells
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157082 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480,20893, 33230,1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
08/21/2003US20030157078 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
08/21/2003US20030157076 Disruption of the Akt2 gene
08/21/2003US20030157070 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
08/21/2003US20030157069 Administering polypeptide; them radiation and drug therapy
08/21/2003US20030157066 Compositions comprising viruses and methods for concentrating virus preparations
08/21/2003US20030157064 Actin gene promoter; genetic engineered polypeptide; cardiovascular disorders
08/21/2003US20030157059 Vaccine; infection therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157054 Recombinant tumor specific antibody and use thereof
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003US20030155434 Spray nozzle apparatus and method of use
08/21/2003DE20308345U1 Injection solution, for use in pyrosequencing equipment, comprises a buffer, deoxynucleotide and an alkaline pH which permits longer sequencing
08/21/2003DE10224200C1 Replicating RNA, useful, after reverse transcription, for analysis on microarrays, comprises conversion to cDNA then reverse transcription of this to form antisense sequences
08/21/2003CA2816242A1 Signal for packaging of influenza virus vectors
08/21/2003CA2752553A1 Anti-cd20 antibodies and fusion proteins thereof and methods of use
1 ... 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 ... 4023